RPA Ecomed

RUSSIAN FEDERATION MINISTRY OF PUBLIC HEALTH
OPEN JOINT-STOCK COMPANY EKRAN RESEARCH AND PRODUCTION ASSOCIATION

129301, Moscow, Kasatkina street, 3		telephone: 283-15-55 fax: 187-37-34 teletype: 113861 NATISK tin 7716011126
No. 6/70		May 26, 1997

To directors of therapeutical and medical preventive institutions and organizations for realization of medical equipment.

Open Joint-Stock Company EKRAN Research and Production Association is recommending you for realization and application in medical network a unique agent for medical purposes: "Electronic Normalizer" - "Autonomous Electrostimulator of Gastrointestinal Tract and Mucosa" (AES GIT & M or EN) designed and produced by the ECOMED research and Production Association (Moscow) in accordance with Technical Specifications 9444-014-11555014-95.

Description of the Electronic Normalizer:

A spherical metal capsule with the maximum dimensions of 11 x 22 mm. It contains a signal generator and a power source inside. It is switched off when stored and switched on automatically when swallowed. It can be easily swallowed even by children older 4 years, because it stimulates the reflex of swallowing.

The effect is achieved by the influence of special electric signals, which increases bioelectric, motor, and secretory activities of all the sections of gastrointestinal tract as well as through peripheral nervous system of organs and systems, making possible to recover normal correlation links and correct metabolism of carbohydrates, lipides, and hormones.

Even a single application of the Electronic Normalizer produces a highly effective positive result prolonged for up to one year.

The Electronic Normalizer is not toxic and does not result in any secondary negative consequences; it is a chemical-free and non-allergic agent for therapy, permitted for sale without prescription (instruction for medical applications is approved on November 21, 1991 by the Head Department for Medical Equipment of the USSR Ministry of Public Hcaltli with supplement dated July 11, 1995).

The electronic normalizer is administered by the following means: per os, per rectum, intravaginal, into opening of preternatural anus, and operative intestinal sections.

Indications for use:

constipations, atony, and intestinal paresis of any genesis (postoperative, postnatal, due to spinal traumas), including those on the background of peritonitis; prevention of development of hemorrhoid, necessary detoxication ofgastrointestinal tract;
functional duodenostasis and postcholesystoctomic syndrome, hypomotor and hypotonic dyskinesia of extraliepatic biliary ducts, recovery of bile formation dynamics;
helmintose duodenostasis, dyskinesia of biliary ducts, including those in chronic opisthorchosis and after treatment with such preparations as Prasiquantel;
recovery of functions and dynamics of duct system of pancreas, elimination of chronic pancreatitis, therapy of diabetes II type, normalizing of carbohydrate and lipide metabolism, the second application of the Electronic Normalizer results in thirty days in a 2.4-fold increase in the concentration of LPVP and in a 1.6-fold decrease in the concentration of LPNP; this effect is prolonged up to one year;
in oncology: excretion of fecal masses for patients with preternatural anus;
in treatment of sexual pathology: it is recommended to provoke menstrual cycle if 1-2 day delay, to improve women sexual activity, to treat prostatitis and to strength men erection;
resuscitation and body de-toxication in emergency, including field states.

Additional indications:

(under medical institutions' report):

for treatment of hyperacid gastritis and gastroduodenal ulcer (Preceding of the Siberian Medical University dated 30/12/1992);
for normalizarion of carbohydrate, lipoid, gormons metabnolism, cholesterin decreasing, including hereditary hyperlipidemia and dyslipoproteinemia correction, in diabetes mellitus, atherosclerosis, decreased number of estrogen and testosterone, to prolong reproductive period (reports dated 18 03 1992 ad 20 03 1997, Act dated 24 12 1992 of the Diabetes Institute under the Russian Academy of Medical Sciences and Endocrinology Chair of the Moscow medical Academy named after I.M.Sechenov);
for immunity correction, including bronchial asthma and allergies - to raise IgA, to descrease IgE (report dated 22.12.1994, reference dated 12.01.1995 of Scientific and researching Institute of Pulmonology and Moscow Department of Health);
in oncology: to limit creation of tumor cells clonning, to improving anti-tumor activeness of phagocyt and organism resistent against tumor, in unnatural anus (report and conclusion dated 10 01 1995 Scientific and Researching Institute of Children Hematology).

Contraindictions:

physical intestinal obstruction, stenosis, internal hemorrhage.

Performances of "EN"are modified in a range of specialists in different fields of medicine and in this connection "Ecomed" is carrying out clinical researching of wide range in order to extend fields of application and to produce effective items of specific actions.

"EN" by "Ecomed" is successfuly tested by FDA (USA), registered in many states and protected with Russian and international patents on design, construction, ways and methods of treating effect.

NOTE:

Nowdays, other manufacturer offer endo-stimulators, electronic and "Kremlin tablets" with statement, on in supporting documentations and even labels, of same performances, directions and contraindictions are not certified by the clinic researcher Results of tests and researchings prove that "Electronical Nornializer" produced by "Ecomed" only meets with harmless standards and therapeutic elfectiveness. Such items have laser marking on its body with statement of the following "Electronny Normalizator", plant No., star and trade mark - "Ecomed" NPO. Revers side of each packing contain the number - TU 9444-014-11555014-95 and bar code - 46055323 or 46055316.

Academician,
General Director /signed/
Seal of the Company by which the document is issued. B. I. Leonov

Back